“…Of the identified extravasation pathways, many are redundant with those of leukocyte homing (Strell and Entschladen, 2008), including interactions between metastatic cell-presented selectin ligands (e.g., sialofucosylated CD44 [Hanley et al, 2006;Subramaniam et al, 2007] and carcinoembryonic antigen [CEA] [Thomas et al, 2008], among others ) with corresponding endothelial-, platelet-, or leukocyte-presented E-, P-, or L-selectin ( Figures 1Aiii and 1Aiv). Given the similarities of these mechanisms with physiologically important homeostatic processes, elucidating cancer cell-specific mechanisms of dissemination is thus crucial to the development of effective therapeutic interventions with highly selective anti-metastatic activity (Li and King, 2012;Oh et al, 2015) and also to the identification of biomarkers for the differentiation of patients with aggressive disease (Baumann et al, 2005;Lech et al, 2016).…”